Cargando…
Insights and lessons learned from a prospective clinical pharmacology study in allogeneic hematopoietic stem cell transplant during the COVID‐19 pandemic
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652756/ https://www.ncbi.nlm.nih.gov/pubmed/34743423 http://dx.doi.org/10.1111/cts.13177 |
_version_ | 1784611612061073408 |
---|---|
author | Zhu, Jing Rao, Gauri Armistead, Paul M. Ptachcinski, Jonathan Weiner, Daniel L. Wiltshire, Tim Crona, Daniel J. |
author_facet | Zhu, Jing Rao, Gauri Armistead, Paul M. Ptachcinski, Jonathan Weiner, Daniel L. Wiltshire, Tim Crona, Daniel J. |
author_sort | Zhu, Jing |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8652756 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86527562021-12-08 Insights and lessons learned from a prospective clinical pharmacology study in allogeneic hematopoietic stem cell transplant during the COVID‐19 pandemic Zhu, Jing Rao, Gauri Armistead, Paul M. Ptachcinski, Jonathan Weiner, Daniel L. Wiltshire, Tim Crona, Daniel J. Clin Transl Sci Perspectives John Wiley and Sons Inc. 2021-11-07 2022-03 /pmc/articles/PMC8652756/ /pubmed/34743423 http://dx.doi.org/10.1111/cts.13177 Text en © 2021 The Authors. Clinical and Translational Science published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Perspectives Zhu, Jing Rao, Gauri Armistead, Paul M. Ptachcinski, Jonathan Weiner, Daniel L. Wiltshire, Tim Crona, Daniel J. Insights and lessons learned from a prospective clinical pharmacology study in allogeneic hematopoietic stem cell transplant during the COVID‐19 pandemic |
title | Insights and lessons learned from a prospective clinical pharmacology study in allogeneic hematopoietic stem cell transplant during the COVID‐19 pandemic |
title_full | Insights and lessons learned from a prospective clinical pharmacology study in allogeneic hematopoietic stem cell transplant during the COVID‐19 pandemic |
title_fullStr | Insights and lessons learned from a prospective clinical pharmacology study in allogeneic hematopoietic stem cell transplant during the COVID‐19 pandemic |
title_full_unstemmed | Insights and lessons learned from a prospective clinical pharmacology study in allogeneic hematopoietic stem cell transplant during the COVID‐19 pandemic |
title_short | Insights and lessons learned from a prospective clinical pharmacology study in allogeneic hematopoietic stem cell transplant during the COVID‐19 pandemic |
title_sort | insights and lessons learned from a prospective clinical pharmacology study in allogeneic hematopoietic stem cell transplant during the covid‐19 pandemic |
topic | Perspectives |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652756/ https://www.ncbi.nlm.nih.gov/pubmed/34743423 http://dx.doi.org/10.1111/cts.13177 |
work_keys_str_mv | AT zhujing insightsandlessonslearnedfromaprospectiveclinicalpharmacologystudyinallogeneichematopoieticstemcelltransplantduringthecovid19pandemic AT raogauri insightsandlessonslearnedfromaprospectiveclinicalpharmacologystudyinallogeneichematopoieticstemcelltransplantduringthecovid19pandemic AT armisteadpaulm insightsandlessonslearnedfromaprospectiveclinicalpharmacologystudyinallogeneichematopoieticstemcelltransplantduringthecovid19pandemic AT ptachcinskijonathan insightsandlessonslearnedfromaprospectiveclinicalpharmacologystudyinallogeneichematopoieticstemcelltransplantduringthecovid19pandemic AT weinerdaniell insightsandlessonslearnedfromaprospectiveclinicalpharmacologystudyinallogeneichematopoieticstemcelltransplantduringthecovid19pandemic AT wiltshiretim insightsandlessonslearnedfromaprospectiveclinicalpharmacologystudyinallogeneichematopoieticstemcelltransplantduringthecovid19pandemic AT cronadanielj insightsandlessonslearnedfromaprospectiveclinicalpharmacologystudyinallogeneichematopoieticstemcelltransplantduringthecovid19pandemic |